ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,889, issued on Oct. 7, was assigned to Mannkind Corp. (Westlake Village, Calif.).
"Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them" was invented by Thomas Hofmann (Doylestown, Pa.), Stefan Ufer (Raleigh, N.C.) and Kevin Stapleton (Laguna Beach, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to pharmaceutical compositions for inhalation comprising a therapeutically effective dose of clofazimine wherein the clofazimine is provided in the form of a suspension, and processes for their preparation. Furthermore, the present invention provides p...